News
-
-
-
COMMUNIQUÉ DE PRESSE
Join AIML's Live Shareholder Update with Chairman & CEO Paul Duffy
AI/ML Innovations Inc. invites stakeholders to Livestream Company Update to review key milestones of 2025 and outline goals for 2026, focusing on commercialization and growth of AI-powered healthcare technologies -
-
-
COMMUNIQUÉ DE PRESSE
AIML Announces Engagement of Guerilla Capital for Communications and Investor Outreach Efforts
AI/ML Innovations Inc. engages Guerilla Capital for investor relations services, enhancing communications and outreach efforts. Terms include Cdn$120,000 fee over 12 months, with possible extension and early termination option -
-
-
COMMUNIQUÉ DE PRESSE
AIML subsidiary NeuralCloud Solutions Signs Commercial Term Sheet with Culminate H Labs to Deploy MaxYield(TM) and Insight360(TM) into INTRINSICA's DNA-Guided Biofeedback Wellness Ecosystem
NeuralCloud partners with Culminate H Labs to integrate MaxYield™ for advanced cardiac signal processing in the INTRINSICA platform, enhancing precision health and consumer monitoring capabilities -
